LobbyingPaperbirch Strategies on Behalf of AP3 Biomedical lobbying by quarter
Paperbirch Strategies on Behalf of AP3 Biomedical's latest lobbying report covers Q2 2026, at $40K. The four quarters Q4 2025–Q3 2026 total $120K. Its first report covers Q3 2025; the issues it reports most are Health Issues.
Paperbirch Strategies on Behalf of AP3 Biomedical
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $120K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2025 | $20K | 1 |
| Q4 2025 | $40K | 1 |
| Q1 2026 | $40K | 1 |
| Q2 2026 | $40K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$140K · 4 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES4 reports
- SENATE1 reports
Firms it paid
| Firm | ||
|---|---|---|
| W Strategies | $140K | 4 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| DARREN WILLCOX | Asst. for Policy, Speaker Dennis Hastert; Admin. Asst., Legislative Director, Legislative Asst., Cong. Porter Goss; House Rules Comm. Assoc., Subcommittee Staff Director | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | W Strategies | $40K |
| 04/18for Q1 | W Strategies | $40K |
| 01/20for Q4 2025 | W Strategies | $40K |
| 25/10/20for Q3 2025 | W Strategies | $20K |
| 25/09/25for Q3 2025 | W Strategies | Under $5,000 |